Latest Biogen Idec Stories
On track to initiate Phase 3 study in infants with SMA in the middle of this year CARLSBAD, Calif., Feb. 21, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
--Isis will receive $9.3 million in milestone payments -- CARLSBAD, Calif., Feb. 13, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
Significant Clinical and Preclinical Data Presentations in Fourth Quarter of 2013 Highlight Transformational Year RICHMOND, Calif., Feb. 11, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
CAMBRIDGE, Mass., Feb.
CHICAGO, Jan. 14, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog.
SHANGHAI, Jan. 13, 2014 /PRNewswire/ -- ShangPharma Corporation is pleased to announce that Dr. Mitchell Reff has joined the company as Chief Biologics Officer. Dr.
RICHMOND, Calif., Jan. 9, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
--Partnership to Focus on Developing Novel Therapies for Sickle Cell Disease and Beta-Thalassemia-- CAMBRIDGE, Mass. and RICHMOND, Calif., Jan.
- The practice of two or more parties jointly purchasing all or part of a butchered cow and dividing the meat between them.